Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy
Jianan Zhao, Yiyang Hu, Jinghua Peng
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
Jianan Zhao, Ping Jiang, Shicheng Guo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 161
An overview of ferroptosis in non-alcoholic fatty liver disease
Shendong Wang, Zhaojun Liu, Jiafeng Geng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113374-113374
Open Access | Times Cited: 72
Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications
Jianan Zhao, Kai Wei, Ping Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 65
Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis
Wenchang Yang, Kaixiong Tao, Yaxin Wang, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115338-115338
Closed Access | Times Cited: 40
Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation
Mengmeng Yang, Longqing Xia, Jia Song, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Ferroptosis: Biology and Role in Gastrointestinal Disease
Juan-José Escuder‐Rodríguez, Deguang Liang, Xuejun Jiang, et al.
Gastroenterology (2024) Vol. 167, Iss. 2, pp. 231-249
Closed Access | Times Cited: 12
Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?
Giovanni Tarantino, Vincenzo Citro
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1993-1993
Open Access | Times Cited: 10
Irisin alleviates hepatic steatosis by activating the autophagic SIRT3 pathway
Ying Zhao, Jia Li, Anran Ma, et al.
Chinese Medical Journal (2025)
Open Access | Times Cited: 1
Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?
Jia-Yue Duan, Xiao Lin, Feng Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 52
The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment
Binbin Zhang, Jianan Zhao, Minjie Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B. Patel
World Journal of Gastroenterology (2023) Vol. 29, Iss. 32, pp. 4831-4850
Open Access | Times Cited: 19
Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
Qiongbo Wu, Zihao Chen, Yi Ding, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 26
Astaxanthin alleviates PM2.5-induced cardiomyocyte injury via inhibiting ferroptosis
Jingyi Ren, Bowen Yin, Zihao Guo, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 15
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease
Yamei Li, Ping Qi, Siyuan Song, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116585-116585
Open Access | Times Cited: 5
Mechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease
Keying Ni, Lina Meng
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102381-102381
Closed Access | Times Cited: 5
The role of pyroptosis in metabolism and metabolic disease
Zhuyuan Zheng, Shaojie Yang, Wanlin Dai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116863-116863
Open Access | Times Cited: 5
DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
Jianan Zhao, Kai Wei, Cen Chang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus
Yue Xu, Pengchong Li, Ketian Li, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102890-102890
Closed Access | Times Cited: 20
A bibliometric analysis and visualization of nonalcoholic fatty liver disease from 2012 to 2021
Zhipeng Li, Shijie Cao, Shaoli Zhao, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 1961-1971
Closed Access | Times Cited: 11
Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease
Jianan Zhao, Yu Zhao, Yiyang Hu, et al.
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 25
Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review
Jung Yoon Jang, Eunok Im, Yung Hyun Choi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7184-7184
Open Access | Times Cited: 18
G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles
Jianan Zhao, Kai Wei, Ping Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
Reda Albadawy, Amany Helmy Hasanin, Sara H. A. Agwa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10148-10148
Open Access | Times Cited: 17
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications
Jianan Zhao, Shicheng Guo, Steven J. Schrodi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top